JAK Inhibitors as a Barrier to the Destructive Cytokine Storm in COVID-19.

Saeedi-Boroujeni, Ali; Asadi-Samani, Majid

Saeedi-Boroujeni, Ali; Asadi-Samani, Majid.

Saeedi-Boroujeni A; Department of Immunology, Faculty of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran.
Asadi-Samani M; Abadan University of Medical Sciences, Abadan, Iran.

Curr Drug Res Rev ; 14(2): 85-87, 2022.

Article in English | MEDLINE | ID: covidwho-1731674

Subject(s)

COVID-19 Drug Treatment; Janus Kinase Inhibitors; Cytokine Release Syndrome/drug therapy; Cytokines; Humans; Janus Kinase Inhibitors/pharmacology; Janus Kinase Inhibitors/therapeutic use; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Janus Kinase Inhibitors / COVID-19 Drug Treatment Limits: Humans Language: English Journal: Curr Drug Res Rev Year: 2022 Document Type: Article Affiliation country: 2589977514666220304203816

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google